Banjo Health vs Cohere Health
Two payer side prior authorization platforms, splitting on benefit type and on breadth. Banjo is pharmacy benefit weighted, reading prescriber notes directly and producing an inspectable structured recommendation with the evidence attached rather than a score, backed by HITRUST at the risk based tier. Cohere is the broader clinical intelligence platform, covering utilization management, payment integrity, appeals, care management and policy management for health plans, which suits an organisation that wants one consistent model of medical necessity across all of them. The question neither answers, and the one that should decide this, is what proportion of AI recommended denials are overturned on appeal. A platform that is fast and wrong costs more than the staff it replaced, and in this workflow the cost lands on a patient waiting for treatment rather than on the plan.
- It is weighted toward pharmacy benefit rather than medical, which is a genuinely different determination workflow, and it reads prescriber notes directly rather than working from a submitted form alone.
- Its central output is an inspectable structure rather than an opaque score, and every recommendation carries detailed evidence, which is the correct design when the output can result in a denial.
- HITRUST at the risk based two year tier, which incorporates the privacy requirements and is the more demanding assessment rather than the lighter entry level one.
- The platform reaches beyond authorisation into payment integrity, appeals, care management and policy management, so one vendor covers the utilization management estate rather than one decision point.
- The clinical intelligence framing is broader and the customer base larger, which matters when a plan wants a single model of medical necessity applied consistently across functions.
- Accreditation matters here in a way it does not elsewhere, and the stronger accredited posture transfers benefit to the plan rather than leaving it exposed.
Side by Side
| Axis | B Banjo Health |
C Cohere Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Prior authorization is the workflow where an AI output most directly results in care being delayed or denied, and neither vendor publishes a bias evaluation or subgroup performance analysis. Washington's rule states that a carrier is not exempt from prior authorization compliance because it used a third party vendor and requires the programme to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden; establish which accreditations each vendor holds for the specific programme you are buying. Neither publishes pricing. Both should be asked what proportion of AI recommended denials are overturned on appeal, which is the number that reveals whether the model is calibrated or merely fast.